Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Ellison Mark Jason Heath
Relationship:   Chief Development Offi...
City:   Santa Monica
State:   CA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   0    

Indirect Shares

  0      
Direct Value   $0    

Indirect Value

  $0      
Total Shares   0      
Total Value   $0      


                                          Charting Not Avaliable
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

      
       
     Stock price went down :
      
       
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Opiant Pharmaceuticals Inc OPNT Chief Development Offi... 2023-03-02 0 2023-03-02 0    Premium*  
* Premium Members only  

Records found :    12         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
OPNT Opiant Pharmaceuticals In... UK Managing Director   –       –      –    2019-07-29 4 OE $10.00 $300,000 I/I 30,000 30,000 0 -
OPNT Opiant Pharmaceuticals In... UK Managing Director   –       –      –    2019-07-29 4 D $12.26 $300,002 I/I (24,470) 5,530 0 -
OPNT Opiant Pharmaceuticals In... UK Managing Director   –       –      –    2020-01-07 4 A $0.00 $0 I/I 4,150 9,680 0 -
OPNT Opiant Pharmaceuticals In... Chief Development Officer   •       –      –    2021-01-26 4 A $0.00 $0 D/D 7,636 7,636 0 -
OPNT Opiant Pharmaceuticals In... Chief Development Officer   •       –      –    2022-01-04 4 A $0.00 $0 D/D 12,000 19,636 0 -
OPNT Opiant Pharmaceuticals In... Chief Development Officer   •       –      –    2022-06-27 4 A $0.00 $0 D/D 2,000 21,636 0 -
OPNT Opiant Pharmaceuticals In... Chief Development Officer   •       –      –    2023-01-05 4 S $20.20 $36,481 D/D (1,806) 19,830 0 %
OPNT Opiant Pharmaceuticals In... Chief Development Officer   •       –      –    2023-01-09 4 S $20.20 $9,474 D/D (469) 19,361 0 %
OPNT Opiant Pharmaceuticals In... Chief Development Officer   •       –      –    2023-01-27 4 S $20.26 $12,359 D/D (610) 18,751 0 %
OPNT Opiant Pharmaceuticals In... Chief Development Officer   •       –      –    2023-03-02 4 D $20.00 $193,600 I/I (9,680) 0 0 -
OPNT Opiant Pharmaceuticals In... Chief Development Officer   •       –      –    2023-03-02 4 A $0.00 $0 D/D 2,000 2,000 0 -
OPNT Opiant Pharmaceuticals In... Chief Development Officer   •       –      –    2023-03-02 4 D $20.00 $415,020 D/D (20,751) 0 0 -

  12  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed